Loading...
Market
Which continent will Colossal Biosciences expand into by end of 2026?
2
Resolution / Starting Odds
Europe • 25%
Asia • 25%
Africa • 25%
South America • 25%
Official announcements from Colossal Biosciences or news reports
Story
Colossal Biosciences Raises $200M, Valued at $10.2B to Revive Woolly Mammoth, Dodo, and Tasmanian Tiger
Jan 15, 2025, 09:15 PM
Colossal Biosciences, a Dallas-based startup focused on de-extinction, has raised $200 million in a Series C funding round, bringing its valuation to $10.2 billion. The company, which aims to revive extinct species such as the woolly mammoth, dodo, and Tasmanian tiger, has now secured a total of $435 million in funding since its inception in 2021. The latest round was led by TWG Global, with Mark Walter and Thomas Tull at the helm. Colossal plans to use the new funds to expand its team, develop new technologies, and broaden its list of species targeted for de-extinction.
View original story
Similar markets
Europe • 25%
Asia • 25%
South America • 25%
Africa • 25%
The Nature Conservancy • 25%
WWF • 25%
Conservation International • 25%
Other • 25%
Europe • 25%
North America • 25%
Africa • 25%
Latin America • 25%
Europe • 25%
Other • 25%
South America • 25%
Asia • 25%
Asia • 25%
Other • 25%
Europe • 25%
North America • 25%
$10.2B to $15B • 25%
$5B to $10.2B • 25%
Below $5B • 25%
Above $15B • 25%
2 new species • 25%
More than 3 new species • 25%
3 new species • 25%
1 new species • 25%
Europe • 25%
South America • 25%
Other • 25%
Asia • 25%
Europe • 25%
South America • 25%
North America • 25%
Asia • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
North Korea • 20%
European Union • 20%
United Kingdom • 20%
China • 20%
Russia • 20%